Sun Kun

Chairman of the Pediatrics Branch of the Chinese Medical Association, Academic Leader of the Key Discipline of Pediatrics of the Ministry of Education, Dean of the School of Pediatrics, Shanghai Jiao Tong University School of Medicine. President of the 6th Asia-Pacific Society of Pediatric Cardiovascular Diseases, Chief Scientist of the Key Research and Development Program of the Ministry of Science and Technology. He has long been engaged in research on the etiology of pediatric cardiovascular diseases, interventional diagnosis and treatment of congenital heart disease, and intrauterine fetal treatment. He pioneered the concept of "intrauterine pediatrics" globally, proposing it for the first time in 2021. With the aim of preventing and treating developmental diseases, it focuses on the early prevention, screening, diagnosis, and treatment of fetal diseases from fertilization through the perinatal period and even the entire life cycle. On July 17, 2018, Dr. Sun Kun led the completion of Asia's first single-center intrauterine balloon dilation surgery for severe congenital aortic stenosis in a fetus. The hospital is officially preparing to establish the first fetal hospital in China in 2025. The establishment of China's "fetal-newborn-child" interventional diagnosis and treatment system for congenital heart disease has led to a 35.76-fold increase in the annual number of interventional treatments for pediatric congenital heart disease in China, reducing the surgical mortality rate and the rate of serious complications from 0.09% and 1.8% to 0.01% and 0.12%, respectively. Ten new interventional treatment technologies for congenital heart disease have been explored and implemented, with the results disseminated to 313 institutions nationwide. Four guidelines and expert consensus statements have been developed under our leadership. We have published 211 papers as first/corresponding author, including in Circulation and Lancet Digital Health. We have received one second-class National Science and Technology Progress Award, one first-class Shanghai Science and Technology Progress Award, and one Song Qingling Pediatric Medicine Award. We have also been approved as the only Ministry of Education Engineering Research Center in the field of congenital heart disease in my country.